MRVL EQUITY Semiconductors & Related Devices 2027 Quantitative Forecast

Marvell Technology, Inc. Common Stock (MRVL) Stock Price Prediction 2027

Multi-horizon algorithmic price targets, Wall Street consensus calibration, reverse-DCF growth expectations & options volatility valuation

$146.99
$-9.77 (-6.23%)
Market Close: Nov 16, 2026
1-Year Base Target
$152.37 +3.7%
Constant-P/E algorithmic trajectory
Wall St. Consensus
$310.32 Bull $341
Institutional analyst mean target
Risk-Adjusted Consensus Fair Value
$263.77 +79.4% Undervalued
Forward P/E 46.2x • PEG 0.42
AI Quant Stance
HOLD 57/100
RSI 33.0 • MACD Bearish • Downtrend

Executive Forecast Synopsis (2027)

Synthesized fundamental, multiple & technical thesis for MRVL

AI Research Note

MRVL Price Forecast 2027: Our AI models project that MRVL stock will rise to approximately $152.37 by 2027. This represents a potential 3.7% growth from the current trading price of $146.99. The overall market sentiment for MRVL is currently neutral, based on a combination of proprietary technical signals and fundamental analysis.

Fundamental Analysis: Trading at a P/E ratio of 54.1, with its most recent quarterly earnings growing by 50.0%. MRVL shows a complex fundamental profile. Our model evaluates these metrics alongside sector peers and historical performance to derive the 2027 price target. If the company exceeds its current growth projections, there may be further upside beyond our base case scenario.

Technical Outlook: The stock is technically in a downtrend phase. The Relative Strength Index (RSI) is currently 33.0, which suggests the stock is trading in a neutral range. Traders should monitor key support and resistance levels closely, as a breakout or breakdown from current price consolidation will be the primary catalyst for the stock reaching the 2027 predicted target.

Quant Signal & Technical Posture

Composite equity rating reconciled with 1-year target trajectory

Score: 57.2/100
Composite Equity Stance
HOLD (Quant Score 57/100) — HOLD
Active Technical & Price Action Triggers
  • MACD converging near zero line - potential energy building
  • Volume showing distribution (CMF: -0.1379)
  • Recent pattern: Doji - Indecision pattern
MACD Regime: Bearish
Volume Tape: Distribution

MRVL Trajectory & Forecast Curve

Projected price curve from spot ($146.99) across 30D–3Y horizons

Term Structure of Price Targets

Constant-multiple earnings trajectory model

30D – 3Y
Horizon Target Price Implied Return
30 Days Near-Term $147.42 +0.3%
90 Days 1 Quarter $148.34 +0.9%
6 Months Medium-Term $149.68 +1.8%
1 Year Base Model $152.37 +3.7%
2 Years EXTENDED $148.10 +0.8%
3 Years EXTENDED $143.96 -2.1%
Wall Street 12M Consensus Target: $310.32

1-Year Scenario Distribution (Bull / Base / Bear)

Probability-weighted regime outcomes around the 12-month forecast horizon

Regime Matrix
Bull Case 30% Prob
$341.35 +132.2%

Best case scenario if strong fundamentals and market conditions align

Base Case 50% Prob
$152.37 +3.7%

Expected scenario based on current growth trajectory

Bear Case 20% Prob
$106.66 -27.4%

Downside scenario if market headwinds or disappointing results

Reverse-DCF Implied Growth, Supply-Chain Moat & R&D Velocity

Proprietary deep-tech expectations gap, supply-chain bottleneck scoring & patent/filing velocity

Deep-Tech & Valuation Intelligence
Reverse-DCF: What's Priced In Priced Beyond Precedent
Market-Implied 5Y CAGR: 65.2%
Analyst Consensus CAGR: 36.8%
Expectation Gap (Implied vs Est): +28.4 pp
Universe: GPU / AI Accelerators (merchant GPU + custom ASIC silicon) (10%/yr hurdle rate)
Supply-Chain Moat & Nx Model Bottleneck 8/10
Moat: Oligopoly • Position: Chip Design (ASIC)
1Y Modeled
1.01x
3Y Modeled
0.92x
5Y Thesis Adj
0.62x
R&D & Commercialization Velocity +1 R&D Citations (7d)
90D Commercialization Mentions: 369 disclosures
R&D Publications Tracked: 40 publications
Commercialization Themes:
5G mmWave / MIMO (0) Edge AI / Inference Chips (56) LLM Efficiency / Architecture (172)

Fair Value & Core Fundamentals

PEG-adjusted intrinsic valuation & balance-sheet multiples

+79.4% Undervalued
Risk-Adjusted Consensus Fair Value: $263.77
Spot: $146.99

Risk-Adjusted Consensus Fair Value (85% of Wall Street target) indicates MRVL trades at a discount to its forward earnings growth trajectory (79.4% implied margin of safety).

PEG Ratio
0.42
Attractive (<1.0)
Implied Fair P/E
82.9x
Model Growth 111.1%
Trailing P/E
54.10x
Forward P/E
46.22x
P/S Ratio (TTM)
15.66x
Rev Growth (YoY)
36.5%
EPS Growth (YoY)
50.0%
Market Cap
$147,966M
52-Week High
$329.88
52-Week Low
$70.69

Technicals & Institutional Money Flow

Momentum oscillators, volume accumulation & key price levels

Distribution
Volume Tape: Distribution

Volume-weighted price action shows near-term supply/distribution pressure; watch support levels for stabilization.

RSI (14-Day)
33.0
Neutral
MACD Signal
Bearish
Primary Trend
Downtrend
Chaikin Money Flow
-0.138
Money Flow Index
27.1
200-Day SMA
$239.06

Options Volatility Valuation: 1-Year Target Strike Strategy

Comparing LEAP Call Implied Volatility & Breakeven against the 1-Year Model Target — Derivative Strategy Signal, NOT an Equity Stock Rating

Options Strategy Only Strategy Score: 1/100
OPTIONS STRATEGY: OVERWRITING / CREDIT SPREADS
SELL COVERED CALLS / COLLECT PREMIUM (Options Overpriced vs. Target)
This is an Options Volatility Valuation signal (comparing Call IV to 1Y target), NOT a sell rating on MRVL shares.
Rich Call Premium (Write / Overwrite)
Premium Collected
$43.20/sh
Profit at 1Y Target
$43.20/sh
Option Writer ROI
+100.0%
Applicable Structures
Covered Call (safest) • Naked Call (risky) • Credit Spread (defined risk)
Why Options Are Flagged for Premium Selling: The $165 Call (Dec 2027) requires MRVL to exceed $208.20 at expiration just to break even. Because the conservative constant-P/E 1Y model target is $152.37, buying out-of-the-money calls carries negative expected value (Buyers lose 100.0% even if target hits. Premium is overpriced for 2.6% move.), whereas shareholders overwriting covered calls capture rich implied volatility.
1Y Constant-PE Target
$152.37
+2.6% vs spot
Evaluated Call Strike
$165.00
Exp: Dec 17, 2027
Call Mark Premium
$43.20
29.1% of spot price
Call Buyer Breakeven
$208.20
Above 1Y base target
Delta / Implied Prob
60.1%
Option market odds
Contract Liquidity
118 OI
Vol: 17 • Nov 16

Unusual Options Flow Alert (Short-Term Derivative Tape)

Short-term institutional sweep & implied volatility anomaly monitor (distinct from long-term equity rating)

Strong Alert (Options Flow)
Flow Alert Score
85/100
Tape Classification
Strong Alert (Options Flow)
Unusual Volume Score
80.0
Implied Volatility Spike
+83.2%
Derivative Tape Readout: Short-Term Derivative Tape: Strong unusual activity detected. Review for potential entry. (Reflects options volume & IV anomalies, not a long-term stock rating.)

Frequently Asked Questions (MRVL 2027 Outlook)

What is the MRVL stock price prediction for 2027?

Based on our AI analysis, MRVL is predicted to reach $152.37 by 2027, representing a potential 3.7% increase from the current price of $146.99.

Is MRVL stock a good buy right now?

Our analysis rates MRVL as a HOLD (AI Quant Score 57.2/100) based on current technical and fundamental indicators. With a projected 3.7% upside in our 1-year constant-P/E model, investors should consider their risk tolerance and investment horizon.

What is MRVL 52-week high and low?

MRVL has a 52-week high of $329.88 and a 52-week low of $70.69. The stock is currently trading 55.4% below its 52-week high.

What is the technical analysis for MRVL?

MRVL is currently in a downtrend trend. The RSI of 33.0 indicates the stock is trading in neutral territory. Traders should monitor support and resistance levels for potential entry points.

Where will MRVL stock be in 3 years?

Our long-term projection estimates MRVL could reach $143.96 by 2029, representing a 2.1% decline from current levels. Long-term predictions carry more uncertainty.

Quantitative Research Disclaimer: Price predictions, reverse-DCF expectations, and options volatility strategies are generated algorithmically from historical financial data, analyst consensus estimates, and live options chains. They are provided strictly for informational and research purposes and do not constitute investment advice. Always conduct independent due diligence before executing equity or derivative transactions.